TACR3 and colitis: Further, it was demonstrated by using selective nonpeptide NK-lR (SR 140333), NK-2R (SR 48968), and NK-3R (SR 142801) antagonists, NK-lR and NK-2R but not NK-3R antagonists reduced colonic inflammation in a rat model of TNBS-induced colitis [76].